These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2540495)

  • 1. Clinical utility of DNA gyrase inhibitors.
    Neu HC
    Pharmacol Ther; 1989; 41(1-2):207-21. PubMed ID: 2540495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should the use of gyrase inhibitors be limited to hospitals?].
    Shah PM
    Immun Infekt; 1990 Jun; 18(3):69-70. PubMed ID: 2165996
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinolones: a new class of antimicrobial agents with wide potential uses.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):623-36. PubMed ID: 3280910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
    Priyanka ; Singh V; Ekta ; Katiyar D
    Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone antibacterials. An update of their pharmacology and therapeutic use.
    von Rosenstiel N; Adam D
    Drugs; 1994 Jun; 47(6):872-901. PubMed ID: 7521829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone generations: natural history or natural selection?
    Ball P
    J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():17-24. PubMed ID: 10997595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
    Hooper DC
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial property and clinical effect of gatifloxacin, a novel quinolone antibacterial agent].
    Hosaka M
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):447-56. PubMed ID: 12835539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quinolones. Gyrase inhibitors].
    Höffler D
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones: structure-activity relationship of Q-35 analogs.
    Ito T; Kojima K; Koizumi K; Nagano H; Nishino T
    Biol Pharm Bull; 1994 Jul; 17(7):927-30. PubMed ID: 8000379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of the quinolones.
    Andriole VT
    Drugs; 1999; 58 Suppl 2():1-5. PubMed ID: 10553697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone mode of action.
    Hooper DC
    Drugs; 1995; 49 Suppl 2():10-5. PubMed ID: 8549276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gatifloxacin Kyorin Pharmaceutical Co.
    Brown WM
    Curr Opin Investig Drugs; 2000 Sep; 1(1):35-44. PubMed ID: 11249593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of gyrase by 4-quinolones: effect on the structure of DNA].
    Weisser J; Wiedemann B
    Infection; 1986; 14 Suppl 3():S183-5. PubMed ID: 3019897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.